- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04910672
Primary Dysmenorrhea and Osteopathic Treatment
Effectiveness of Osteopathic Treatment in Patients With Primary Dysmenorrhea
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Sara S Tello, PT
- Phone Number: 651458007
- Email: sara_santiago_tello@hotmail.com
Study Contact Backup
- Name: Miriam C Lozano, PT
- Phone Number: 677540058
- Email: myriam.corona.lozano@gmail.com
Study Locations
-
-
Cádiz
-
Arcos de la Frontera, Cádiz, Spain, 11630
- Miriam Corona Lozano
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Crampy pain in the lower abdomen or lumbo-pelvic area between 8 hours and 4 days after menstrual bleeding.
- Clinical evolution of at least three menstrual cycles with said pathology.
- Moderate menstrual pain or severe intensity, minimum 5 VAS scale.
- Regular menstrual cycle, between 21 and 35 days.
- Accept informed consent.
Exclusion Criteria:
- Being receiving any other physiotherapeutic or pharmacological treatment for primary dysmenorrhea during the 3 weeks prior to the beginning of the intervention.
- Suffering from cardiovascular diseases, prolapse, amenorrhea, hemophilia, tumor or infectious processes, use of IUDs, consumption of oral contraceptives or suffering from any injury that affects the sensory-motor function.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control Group
The control group (n = 30) will only carry out a bilateral global pelvic manipulation
|
Bilateral global pelvic manipulation. Lower right limb in extension. The left lower limb in flexion, until the tension on the SPIS was felt. Introduce very little rotation of the spine. ASI anterior slide until crease forms at waist. We bring the elbow towards our hips. We rotate the patient posteriorly to open the lumbo sacral facet. The thrust is performed by simultaneously increasing these three parameters, with kick and joint compression. |
|
Experimental: Experimental Group
The experimental group (n = 30) will be treated following an osteopathic treatment, through a bilateral global pelvic manipulation and a specific internal technique for mobility of the cervix
|
Bilateral Global Pelvic Manipulation and Internal Correction Technique for Laterflexion of the Uterus The technique consists of making contact with the vaginal fingers on the upper and anterior part of the cervix, while the abdominal hand, dragging the skin towards the pubis, tries to make contact as posterior as possible on the fundus of the uterus. The technique consists, while the patient breathes widely, in progressively raising the uterine fundus forward and upward and lowering the cervix until the normal anteversion position is achieved. At the end of the technique, fixing the correction position of the uterus, we can ask the patient to perform a pelvic anteversion, while the correction is maintained. At the end of the technique, all abnormal tension should have disappeared and the uterus should have recovered a physiological position of anteversion. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from Baseline in the Visual Analogue Scale (pain) during menstruation at week 4, 8 and 10.
Time Frame: Baseline and week 4, 8 and 10
|
Measured before the treatment in each meeting, asking about the pain during the last menstrual period.
The higher is the value of the scale, the worse.
|
Baseline and week 4, 8 and 10
|
|
Change from Baseline in the Specific Quality of Life Questionnaire Related to Menstruation CVM-22 at weeks 4, 8 and 10
Time Frame: Baseline and weeks 4, 8 and 10
|
The CVM-22, self-administered Likert type, is made up of 22 items.
The questionnaire score ranges from 0 to 66, where the higher the score the worse the CVM-22.
|
Baseline and weeks 4, 8 and 10
|
|
Change from Baseline in the Questionnaire on sexual health and detection of female sexual dysfunctions in primary care (SyDSF-AP) at weeks 4, 8 and 10
Time Frame: Baseline and weeks 4, 8 and 10
|
Self-administered questionnaire of 20 closed questions, although 8, 9 and 19 have an open component, and 1 is an open question, which is integrated into domains.
Those of the descriptive sociodemographic domain and the health condition help to know the profile of the surveyed women, as well as the factors that may influence their sexuality.
The domain of sexual function ranges from question 10 to 18 and is answered using a Likert scale of 5 values.
In addition, question 20 has been included to assess satisfaction with your partner from 0 to 10. Finally, question 21 is open to collect the comments that may arise during the completion of the questionnaire.
|
Baseline and weeks 4, 8 and 10
|
|
change from baseline in the values of the pressure algometer measured on 9 different points at weeks 4, 8 and 10.
Time Frame: Pre-intervention and post-intervention in Baseline and weeks 4 and 8. Another measure without intervention in week 10.
|
The Pressure Threshold is defined as the minimum pressure that triggers a painful response.
The WAGNER brand "FORCE TEN" pressure algometer was used to quantify the Pressure Thereshold at the 9 sensitive pressure points of dysmenorrhea.
The rubber tip was used to focus the pressure exerted by the evaluator and it was placed perpendicular to each point.
The measurements were carried out 3 times for each point (with 10 seconds of difference between each measurement, 30 before moving on to another point) and calculating the mean value.
Before carrying out the measurements, the patients were instructed in the procedure, giving as an example an area not included in the assessment.
When the pressure sensation started to be painful, they should tell the evaluator.
|
Pre-intervention and post-intervention in Baseline and weeks 4 and 8. Another measure without intervention in week 10.
|
|
Change from baseline in Medication intake during the menstrual period at weeks 4, 8 and 10.
Time Frame: Baseline and weeks 4, 8 and 10
|
The average consumption of NSAIDs by the dose of medication used, self-reported responses by the participants.
It will be recorded in a journal that will be given to them to write down.
|
Baseline and weeks 4, 8 and 10
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: François Ricard, DO, Escuela Osteopatía Madrid
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- OsteopatiaMadrid
- MCLozano (Other Identifier: OsteopatiaMadrid)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sexual Dysfunction
-
NYU Langone HealthNot yet recruitingSexual Dysfunction | Urinary DysfunctionUnited States
-
Istanbul University - Cerrahpasa (IUC)CompletedSexual Dysfunction | Pregnancy Related | Postpartum Sexual DysfunctionTurkey
-
London Metropolitan UniversityBarts & The London NHS Trust; Homerton University Hospital NHS Foundation TrustNot yet recruitingSexual Dysfunction
-
BayerCompletedSexual Dysfunction | Male Erectile DysfunctionBelgium, Italy, France, Germany, Spain, Netherlands, South Africa
-
University of MichiganThe Craig H. Neilsen Foundation; International Society for the Study of Women...CompletedFemale Sexual Dysfunction | Female Sexual Dysfunction Due to Physical ConditionUnited States
-
Stony Brook UniversityCompletedFemale Sexual DysfunctionUnited States
-
McGill University Health Centre/Research Institute...RecruitingInfertility | Sexual Behavior | Sexual Function | Assisted Reproductive Techniques | Sexual Dysfunction Female | Sexual Dysfunction and Infertility | Infertility Assisted Reproductive TechnologyCanada
-
Cairo UniversityCompleted
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedGynecologic Cancer | Sexual DysfunctionUnited States
Clinical Trials on Control Group
-
Tasly Pharmaceutical Group Co., LtdCompleted
-
Chengdu Sport UniversityNot yet recruiting
-
Hanlim Pharm. Co., Ltd.Recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
International University of La RiojaCompletedPsychosis | Therapy | PsychologicalSpain
-
The First Affiliated Hospital of Zhejiang Chinese...Not yet recruitingAdolescent Idiopathic ScoliosisChina
-
The University of Hong Konghong Kong Cancer FundCompletedBreast Cancer | Yoga Therapy | Shoulder Joint Motion | Scar Contracture
-
Romanian Society of Anesthesia and Intensive CareUniversity of Medicine and Pharmacy "Victor Babes" Timisoara; Timişoara County...Completed
-
Helse Stavanger HFUniversity of Oslo; Oslo University Hospital; University College, London; Aalborg... and other collaboratorsNot yet recruitingPTSD | Personality Disorder, Borderline | Personality Disorder | Personality Trait | PTSD - Post Traumatic Stress Disorder | Personality Type | PTSD and Trauma-related Symptoms | Personality Disorder, Avoidant | Affect Consciousness | Mentalization | Reflective FunctioningNorway